In 2009, the Medicines and Healthcare products Regulatory agency published a Drug Safety Update reporting on a cohort study which looked at whether varenicline was associated with an increased risk of suicidal behaviour vs. bupropion or nicotine replacement therapy. The study found no clear evidence of an increased risk with varenicline.